DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cabergoline (Cabergoline) - Neoplasm Progression - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Neoplasm Progression (9)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cabergoline where reactions include neoplasm progression. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Cabergoline side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-07-27

Patient: 30 year old female

Reactions: Menstrual Disorder, Galactorrhoea, Prolactinoma, Neoplasm Progression, Drug Interaction

Drug(s) suspected as cause:
Cabergoline
    Dosage: 2 mg, twice weekly

Cabergoline
    Dosage: 0.25 mg, twice weekly

Other drugs received by patient possibly interacting with the suspect drug:
Bromocriptine Mesylate
    Dosage: 15 mg, daily

Bromocriptine Mesylate
    Dosage: 7.5 mg, daily

Bromocriptine Mesylate
    Dosage: 20 mg, daily

Oxcarbazepine
    Dosage: 600 mg daily
    Indication: Convulsion

Oxcarbazepine
    Dosage: 1200 mg daily

Other drugs received by patient: Quinagolide; Quinagolide



Possible Cabergoline side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-07-27

Patient: 30 year old female

Reactions: Galactorrhoea, Menstrual Disorder, Prolactinoma, Drug Interaction, Neoplasm Progression

Drug(s) suspected as cause:
Cabergoline
    Dosage: 0.25 mg, twice weekly

Cabergoline
    Dosage: 2 mg, twice weekly

Other drugs received by patient possibly interacting with the suspect drug:
Bromocriptine Mesylate
    Dosage: 20 mg, daily

Bromocriptine Mesylate
    Dosage: 7.5 mg, daily

Bromocriptine Mesylate
    Dosage: 15 mg, daily

Oxcarbazepine
    Dosage: 600 mg daily
    Indication: Convulsion

Oxcarbazepine
    Dosage: 1200 mg daily

Other drugs received by patient: Quinagolide; Quinagolide



Possible Cabergoline side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-06-26

Patient: 30 year old female

Reactions: Menstrual Disorder, Galactorrhoea, Prolactinoma, Drug Interaction, Neoplasm Progression

Drug(s) suspected as cause:
Cabergoline
    Dosage: 0.25 mg, twice weekly

Cabergoline
    Dosage: 2 mg, twice weekly

Other drugs received by patient possibly interacting with the suspect drug:
Bromocriptine Mesylate
    Dosage: 7.5 mg, daily

Bromocriptine Mesylate
    Dosage: 20 mg, daily

Bromocriptine Mesylate
    Dosage: 15 mg, daily

Oxcarbazepine
    Dosage: 600 mg daily
    Indication: Convulsion

Oxcarbazepine
    Dosage: 1200 mg daily

Other drugs received by patient: Quinagolide; Quinagolide



Possible Cabergoline side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-06-26

Patient: 30 year old female

Reactions: Galactorrhoea, Menstrual Disorder, Prolactinoma, Neoplasm Progression, Drug Interaction

Drug(s) suspected as cause:
Cabergoline
    Dosage: 0.25 mg, twice weekly

Cabergoline
    Dosage: 2 mg, twice weekly

Other drugs received by patient possibly interacting with the suspect drug:
Bromocriptine Mesylate
    Dosage: 7.5 mg, daily

Bromocriptine Mesylate
    Dosage: 15 mg, daily

Bromocriptine Mesylate
    Dosage: 20 mg, daily

Oxcarbazepine
    Dosage: 1200 mg daily

Oxcarbazepine
    Dosage: 600 mg daily
    Indication: Convulsion

Other drugs received by patient: Quinagolide; Quinagolide



Possible Cabergoline side effects in 64 year old male

Reported by a physician from France on 2012-03-29

Patient: 64 year old male

Reactions: Visual Field Defect, Prolactinoma, Neoplasm Progression, Condition Aggravated

Drug(s) suspected as cause:
Cabergoline

Other drugs received by patient: Levothyroxine Sodium; Testosterone Enanthate



Possible Cabergoline side effects in 42 year old female

Reported by a health professional (non-physician/pharmacist) from Brazil on 2012-03-12

Patient: 42 year old female

Reactions: Drug Ineffective, Neoplasm Progression

Drug(s) suspected as cause:
Cabergoline
    Dosage: 0.5 mg per day

Cabergoline
    Dosage: 0.5 mg, 3 times a week
    Indication: Adenoma Benign



Possible Cabergoline side effects in 31 year old male

Reported by a health professional (non-physician/pharmacist) from Russian Federation on 2011-11-18

Patient: 31 year old male

Reactions: Drug Ineffective, Visual Impairment, Neoplasm Progression, Headache

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-10

Patient: 50 year old male

Reactions: Neoplasm Progression, Skin Hyperpigmentation, Headache, Death, Fatigue, Aspiration, Eye Movement Disorder, Pupillary Reflex Impaired, Back Pain, Dysphagia, Hyperglycaemia, Muscular Weakness, Hypoaesthesia, Hemianopia, Blood Corticotrophin Increased, Cortisol Free Urine Increased, Areflexia, Memory Impairment, Anosmia, Metastases To Bone

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cabergoline
    Dosage: 0.5 mg, twice a week
    Administration route: Oral

Metyrapone
    Dosage: 250 mg, bid
    Administration route: Oral

Octreotide Acetate
    Dosage: 300 ug, tid

Octreotide Acetate
    Dosage: 300 ug, tid
    Indication: Blood Corticotrophin Increased

Other drugs received by patient: Capecitabine; Temozolomide; Cisplatin; Etoposide; Rosiglitazone



Possible Cabergoline side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-10

Patient: 50 year old male

Reactions: Neoplasm Progression, Skin Hyperpigmentation, Headache, Death, Fatigue, Aspiration, Eye Movement Disorder, Back Pain, Pupillary Reflex Impaired, Dysphagia, Hyperglycaemia, Muscular Weakness, Hypoaesthesia, Hemianopia, Blood Corticotrophin Increased, Areflexia, Cortisol Free Urine Increased, Memory Impairment, Anosmia, Metastases To Bone

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cabergoline
    Dosage: 0.5 mg, twice a week
    Administration route: Oral

Metyrapone
    Dosage: 250 mg, bid
    Administration route: Oral

Octreotide Acetate
    Dosage: 300 ug, tid

Octreotide Acetate
    Dosage: 300 ug, tid
    Indication: Blood Corticotrophin Increased

Other drugs received by patient: Rosiglitazone; Capecitabine; Cisplatin; Temozolomide; Etoposide

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017